DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 201 filers reported holding DIPLOMAT PHARMACY INC in Q4 2017. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $0 | – | 0 | – | 0.00% | – |
Q1 2021 | $0 | – | 0 | – | 0.00% | – |
Q4 2020 | $0 | – | 0 | – | 0.00% | – |
Q3 2020 | $0 | – | 0 | – | 0.00% | – |
Q2 2020 | $0 | – | 0 | – | 0.00% | – |
Q1 2020 | $0 | – | 0 | – | 0.00% | – |
Q4 2019 | $0 | – | 0 | – | 0.00% | – |
Q3 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
Q1 2018 | $25,000 | 0.0% | 1,231 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $25,000 | -59.0% | 1,231 | -58.0% | 0.00% | -50.0% |
Q3 2017 | $61,000 | +22.0% | 2,931 | -12.5% | 0.00% | 0.0% |
Q2 2017 | $50,000 | -2.0% | 3,351 | +4.1% | 0.00% | 0.0% |
Q1 2017 | $51,000 | +59.4% | 3,220 | +26.3% | 0.00% | 0.0% |
Q4 2016 | $32,000 | +28.0% | 2,550 | +185.6% | 0.00% | +100.0% |
Q3 2016 | $25,000 | +212.5% | 893 | +288.3% | 0.00% | – |
Q2 2016 | $8,000 | -20.0% | 230 | -24.6% | 0.00% | -100.0% |
Q4 2015 | $10,000 | – | 305 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 7,036,670 | $42,853,000 | 1.54% |
ARMISTICE CAPITAL, LLC | 3,200,000 | $19,488,000 | 1.23% |
STEPHENS INC /AR/ | 6,600,015 | $40,194,000 | 0.91% |
S&T BANK/PA | 610,367 | $3,718,000 | 0.82% |
Rhenman & Partners Asset Management AB | 1,203,405 | $7,329,000 | 0.81% |
Matarin Capital Management, LLC | 701,445 | $4,272,000 | 0.30% |
Investors Research Corp | 89,727 | $546,000 | 0.28% |
Advisory Services Network, LLC | 598,802 | $3,647,000 | 0.22% |
FCG ADVISORS, LLC | 34,000 | $207,000 | 0.06% |
EVERENCE CAPITAL MANAGEMENT INC | 52,730 | $321,000 | 0.05% |